Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 01, 2024 08:15 ET | Source: Clearmind Medicine Inc.

Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with Leading Israeli Research Center

The licensing agreement refers to the company's dedicated treatment for cocaine addiction which previously indicated a significant decrease in cocaine craving Tel Aviv, Israel / Vancouver,...
December 05, 2023 08:47 ET | Source: Clearmind Medicine Inc.

Clearmind Medicine Achieved Positive Results in Cocaine Addiction Treatment

Tel Aviv, Israel / Vancouver, Canada, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the "company"), a biotech company focused on...
October 17, 2023 12:45 ET | Source: American College of Medical Toxicology

Opioid and Stimulant Overdose Reporting Program to Expand Under Increased Federal Funding

Phoenix, AZ, Oct. 17, 2023 (GLOBE NEWSWIRE) -- In September of 2022, the FDA awarded the American College of Medical Toxicology’s (ACMT) Toxicology Investigators Consortium (ToxIC) a 5-year $7.9...
December 23, 2015 09:00 ET | Source: Opiant Pharmaceuticals, Inc.

Lightlake Therapeutics Inc. Announces Collaboration With NIDA and the Perelman School of Medicine at the University of Pennsylvania

NEW YORK, Dec. 23, 2015 (GLOBE NEWSWIRE) -- Lightlake Therapeutics Inc. (“Lightlake”) (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use,...
April 28, 2015 14:20 ET | Source: ARUP Laboratories

Born an Addict: ARUP Searches for Clues in the Umbilical Cord

SALT LAKE CITY, April 28, 2015 (GLOBE NEWSWIRE) -- Every baby born that enters this world, arrives with an umbilical cord in tow. For those babies born addicted to drugs, that umbilical cord is now a...
May 19, 2011 08:15 ET | Source: Norchem

Designer Drugs Finally Detectable With Specialty Test From Norchem

FLAGSTAFF, AZ--(Marketwire - May 19, 2011) - A new wave of designer drugs, technically legal because they are labeled "not for human consumption," are no less dangerous than their predecessors,...